P/E Ratio
Higher than 58% of Healthcare sector peers
Updated 1927h ago
Sector Performance
58th percentileABT
28.5x
Sector Median
27.6x
Sector Avg
33.3x
Deep Analysis
The current P/E Ratio of 28.5x means that investors are paying $28.50 for every $1 of the company's earnings per share — a measure of how much the market is willing to pay for each dollar of profit.
Against its Healthcare sector, this ratio sits just above the median of 28.3x, placing ABT in the 56th percentile among peers, meaning it is slightly more expensive than more than half of comparable companies. The metric has been perfectly stable over the last eight quarters, with no change year-over-year or quarter-over-quarter (both +0.0%). A P/E near the sector median combined with a flat trend suggests limited relative mispricing and modest valuation risk, but also no obvious bargain opportunity. This stability aligns with the overall NEUTRAL verdict, as the metric neither signals an overvalued extreme nor a clear entry point for value-oriented investors.
Frequently Asked Questions
What does the P/E Ratio tell investors about ABT?
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
How is the P/E Ratio calculated?
P/E Ratio is calculated as: Price / EPS.
How does ABT's P/E Ratio compare to its sector?
ABT's P/E Ratio of 28.5x compares to a Healthcare sector median of 27.6x, placing it in the 58th percentile.
Who are ABT's closest peers by P/E Ratio?
The closest Healthcare peers by P/E Ratio include: AZN (27.0x), CCLD (28.3x), ALGN (29.1x), AMGN (24.7x), A (23.0x).
The Formula
Price / EPS
Why It Matters
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
Master ABT's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full ABT research report →ABT
28.5x
Sector Median
27.6x
Sector Avg
33.3x
How ABT's P/E Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.